ChinaAMC Hang Seng Hong Kong-Listed Biotech Index QDII ETF (SHE:159892)
0.8010
-0.0100 (-1.23%)
At close: Apr 3, 2026
27.55% (1Y)
| Assets | 5.85B |
| Expense Ratio | 0.65% |
| PE Ratio | 21.32 |
| Dividend (ttm) | n/a |
| Dividend Yield | n/a |
| Ex-Dividend Date | n/a |
| Payout Frequency | n/a |
| Payout Ratio | n/a |
| 1-Year Return | +27.55% |
| Volume | 406,432,400 |
| Open | 0.8070 |
| Previous Close | 0.8110 |
| Day's Range | 0.8010 - 0.8180 |
| 52-Week Low | 0.4870 |
| 52-Week High | 0.9940 |
| Beta | 0.87 |
| Holdings | n/a |
| Inception Date | Sep 29, 2021 |
About 159892
159892.SZ was created on 2021-09-29 by ChinaAMC. The fund's investment portfolio concentrates primarily on health care equity. Closely track underlying index,Tightly track the target and minimize the deviation
Asset Class Equity
Category Health Care
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 159892
Provider ChinaAMC
Index Tracked Hang Seng Biotech Index - HKD - Benchmark TR Net
Performance
159892 had a total return of 27.55% in the past year, including dividends. Since the fund's inception, the average annual return has been -4.64%.